Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Iredale

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Gastroenterology|April 1, 2014
Identifying molecular factors that contribute to resolution of liver fibrosisJohn P Iredale, Ramon Bataller
Journal of Hepatology|December 28, 2010
The inflammatory microenvironment of HCC - the plot becomes complexJörg Schrader, John P Iredale
Annals of Hepatology|December 17, 2009
Reversibility of liver fibrosisPrakash Ramachandran, John P Iredale
Clinical Science (London, England : 1979)|January 31, 2007
Liver fibrosis: cellular mechanisms of progression and resolutionNeil C Henderson, John P Iredale
Expert Opinion on Therapeutic Targets|October 8, 2004
Targeted treatments for cirrhosisJonathan A Fallowfield, John P Iredale
Gastroenterology|August 25, 2012
Standing down the guard: stellate cells leave quietlyNeil C Henderson, John P Iredale
Digestive Diseases (Basel, Switzerland)|May 16, 2006
Emerging therapies for liver fibrosisAndrew J Fowell, John P Iredale
Methods in Molecular Medicine|August 25, 2005
Modeling liver fibrosis in rodentsChristothea Constandinou, Neil Henderson, John P Iredale
Fibrogenesis & Tissue Repair|December 25, 2012
Reversibility of liver fibrosisAntonella Pellicoro, Prakash Ramachandran, John P Iredale
Hepatology (Baltimore, Md.)|February 27, 2009
Senescence of activated stellate cells: not just early retirementJörg Schrader, Jonathan Fallowfield, John P Iredale
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Gastroenterology|April 1, 2014
Identifying molecular factors that contribute to resolution of liver fibrosisJohn P Iredale, Ramon Bataller
Journal of Hepatology|December 28, 2010
The inflammatory microenvironment of HCC - the plot becomes complexJörg Schrader, John P Iredale
Annals of Hepatology|December 17, 2009
Reversibility of liver fibrosisPrakash Ramachandran, John P Iredale
Clinical Science (London, England : 1979)|January 31, 2007
Liver fibrosis: cellular mechanisms of progression and resolutionNeil C Henderson, John P Iredale
Expert Opinion on Therapeutic Targets|October 8, 2004
Targeted treatments for cirrhosisJonathan A Fallowfield, John P Iredale
Gastroenterology|August 25, 2012
Standing down the guard: stellate cells leave quietlyNeil C Henderson, John P Iredale
Digestive Diseases (Basel, Switzerland)|May 16, 2006
Emerging therapies for liver fibrosisAndrew J Fowell, John P Iredale
Methods in Molecular Medicine|August 25, 2005
Modeling liver fibrosis in rodentsChristothea Constandinou, Neil Henderson, John P Iredale
Fibrogenesis & Tissue Repair|December 25, 2012
Reversibility of liver fibrosisAntonella Pellicoro, Prakash Ramachandran, John P Iredale
Hepatology (Baltimore, Md.)|February 27, 2009
Senescence of activated stellate cells: not just early retirementJörg Schrader, Jonathan Fallowfield, John P Iredale
Pageof 11